Advanced stage breast cancer cases had 6.89-fold CNTN-1 mRNA expression while being lower in the early-stage breast cancer cases (1.72-fold) and differences among them were found to be statistically significant (p < 0.0001). This evidence concerns the gene CNTN1 and breast carcinoma.